Table 1.
List of 68 included publications
| Study | Quality score | Cisplatin dose | Obs. period | Study | Quality score | Cisplatin dose | Obs. period |
|---|---|---|---|---|---|---|---|
| Angel et al. (1993) [4] | 7 | 10 mg kg−1, i.v. | 3 h | Minami et al. (1998) [91] | 6 | 10 mg kg−1, i.p. | 6 h |
| Barnes et al. (1987) [6] | 6 | 10 mg kg−1, i.v. | 4 h | Miner et al. (1986a) [94] | 4 | 10 mg kg−1, i.v. | 4 h |
| Barnes et al. (1988) [5] | 9 | 10 mg kg−1, i.v. | 3 h | Miner et al. (1987) [96] | 4 | 10 mg kg−1, i.v. | 4 h |
| Barnes et al. (1991) [7] | 7 | 10 mg kg−1, i.v. | 4 h | Nakayama et al. (2005) [99] | 8.5 | 5, 10 mg kg−1, i.p. | 24, 4 h |
| Bermudez et al. (1988) [9] | 4.5 | 10 mg kg−1, i.v. | 4 h | Ozaki and Sakamoto (1999) [103] | 7 | 10 mg kg−1, i.v. | 4 h |
| Bingham et al. (1994) [11] | 4.5 | 12.5 mg kg−1, i.v. | 4 h | Reynolds et al. (1991) [108] | 6 | 10 mg kg−1, i.p. | 3 h |
| Blower (1990) [12] | 6 | 10 mg kg−1, i.v. | 4 h | Rudd et al. (1992) [111] | 5 | 10 mg kg−1, i.v | 4 h |
| Costall et al. (1986) [21] | 7 | 10 mg kg−1, i.v. | 2 h | Rudd et al. (1994a) [114] | 6.5 | 10 mg kg−1, i.p. | 40 h |
| Costall et al. (1987b) [19] | 6 | 10 mg kg−1, i.v. | 2 h | Rudd and Naylor (1994b) [117] | 5 | 5, 10 mg kg−1, i.p. | 24 h |
| Costall et al. (1987c) [22] | 6.5 | 10, 15 mg kg−1, i.v. | 2 h | Rudd and Naylor (1994c) [118] | 6 | 10 mg kg−1, i.v. | 4 h |
| Costall et al. (1990a) [20] | 7 | 10, 15 mg kg−1, i.v. | 4 h | Rudd et al. (1996b) [115] | 7.5 | 5, 10 mg kg−1, i.p. | 24, 40 h |
| Costall et al. (1990b) [23] | 7 | 10 mg kg−1, i.v. | 4 h | Rudd and Naylor (1996c) [119] | 7.5 | 5 mg kg−1, i.p. | 24 h |
| Davis (1988) [26] | 8 | 10, 12, 20 mg kg−1, i.v. | 2 h | Rudd et al. (1996a) [112] | 8 | 10 mg kg−1, i.v. | 4 h |
| Delagrange et al. (1996) [26, 27] | 3.5 | 10 mg kg−1, i.p. | 5 h | Rudd and Naylor (1997) [120] | 8.5 | 10 mg kg−1, i.p. | 24 h |
| Endo et al. (1990b) [33] | 6 | 7, 10 mg kg−1, i.p. | 6 h | Rudd et al. (1998b) [113] | 5.5 | 10 mg kg−1, i.p. | 24 h |
| Endo et al. (1994) [36] | 6.5 | 10 mg kg−1, i.p. | 6 h | Rudd et al. (2006a) [122] | 6 | 10 mg kg−1, i.p. | 6 h |
| Fink-Jensen (1992) [38] | 5 | 10 mg kg−1, i.v. | 4 h | Rycroft et al. (1996) [127] | 5 | 10 mg kg−1, i.v. | 4 h |
| Florczyk et al. (1982) [40] | 5 | 6, 8, 10 mg kg−1, i.v. | 4 h | Sam et al. (2001) [128] | 7.5 | 5 mg kg−1, i.p. | 24 h |
| Fukunaka et al. (1998) [42] | 8 | 5 mg kg−1, i.p. | 24 h | Sam et al. (2003) [129] | 7.5 | 5 mg kg−1, i.p. | 24 h |
| Gonsalves et al. (1996) [47] | 7.5 | 10 mg kg−1, i.p. | 2 h | Sam et al. (2007) [130] | 7.5 | 5 mg kg−1, i.p. | 24 h |
| Gylys et al. (1988) [49] | 5 | 12 mg kg−1, i.v. | 4 h | Schurig et al. (1982) [131] | 5.5 | 8 mg kg−1, i.p. | 4 h |
| Haga et al. (1993) [50] | 4.5 | 8 mg kg−1, i.v. | 5 h | Shiroshita et al. (1993) [132] | 6 | 10 mg kg−1, i.p. | 6 h |
| Hawthorn et al. (1988) [56] | 8.5 | 10 mg kg−1, i.p. | 4 h | Singh et al. (1997) [134] | 4.5 | 5 mg kg−1, i.p. | 24 h |
| Higgins et al. (1989) [59] | 5.5 | 9 mg kg−1, i.p. | 3 h | Taniguchi et al. (2004) [137] | 5 | 5 mg kg−1, i.p. | 24 h |
| Kamato et al. (1991) [67] | 6.5 | 10 mg kg−1, i.v., i.p. | 4 h | Tattersall et al. (1992) [139] | 7.5 | 10 mg kg−1, i.v. | 4 h |
| Kamato et al. (1993) [66] | 6.5 | 10 mg kg−1, i.v. | 6 h | Tattersall et al. (1993) [142] | 5.5 | 10 mg kg−1, i.v. | 4 h |
| King and Sanger (2005) [70] | 7.5 | 10 mg kg−1, i.p. | 6 h | Tattersall et al. (2000) [140] | 3.5 | 5, 10 mg kg−1, i.p., i.v. | 24, 4 h |
| Lau et al. (2005) [75] | 7.5 | 10 mg kg−1, i.p. | 2 h | Tsuchiya et al. (2002) [144] | 7.5 | 5 mg kg−1, i.p. | 24 h |
| Lehmann and Karrberg (1996) [76] | 7.5 | 10 mg kg−1, i.v. | 3 h | Watson et al. (1995) [148]{ | 7.5 | 10 mg kg−1, i.p. | 2 h |
| Marr et al. (1992) [81] | 6.5 | 10 mg kg−1, i.v. | 4 h | Yamakuni et al. (2002) [150] | 5 | 5, 10 mg kg−1, i.p. | 24, 4 h |
| Marr et al. (1994a) [82] | 7 | 10 mg kg−1, i.v. | 4 h | Yamakuni et al. (2006) [149] | 7.5 | 5, 10 mg kg−1, i.p., i.v. | 24, 4 h |
| Marr et al. (1994b) [83] | 3.5 | 12.5 mg kg−1, i.v. | 4 h | Yoshida et al. (1992a) [151] | 4 | 10 mg kg−1, i.v. | 3 h |
| Miller et al. (1993) [90] | 7 | 10 mg kg−1, i.v. | 4 h | Yoshida et al. (1993) [153] | 4.5 | 10 mg kg−1, i.v. | 3 h |
| Minami et al. (1997) [93] | 6 | 10 mg kg−1, i.p. | 6 h | Yoshikawa et al. (2001b) [157] | 3.5 | 10 mg kg−1, i.v. | 4 h |
For each included study, the quality score (out of 9), the dose and mode of administration of cisplatin and the duration of the acute phase observation period are indicated